IL6 and Myalgia: Due to the importance of IL-6 in immune response, Tocilizumab may have the potential to play a similarly important role in regulation thereof, as there are numerous preclinical and clinical studies investigating further example of application such as giant cell arteritis, polymyalgia rheumatica and large vessel vasculitis (Sheppard et al. 2017).